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Prenatal Diagnosis and 
Management of Sacrococcygeal 
Teratomas
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Abstract
Sacrococcygeal teratomas (SCT) represents a group tumors deriving from the 
primordial germ cells. It is the most common tumor affecting neonates, with a 
female to male ratio of almost 4:1.78. SCT are either benign (mature) or malignant 
(immature) with different outcome. With advancements in ultrasonography, more 
SCT are diagnosed prenatally. magnetic resonance imaging (MRI) is more accurate in 
describing the intrapelvic and abdominal extent of the tumor. Most fetal teratomas 
could be managed by planned delivery and postnatal surgery. The earlier the diagno-
sis and surgical intervention, the better the prognosis. A complete surgical excision 
of the tumor is necessary, including coccygectomy, to prevent recurrence. At the time 
of birth, most lesions are benign and surgical resection can be accomplished with 
relatively low morbidity and mortality. Recurrence is reported as 2–35% in patients 
with immature teratomas, tumor spillage, incomplete resection or failure to remove 
the coccyx. A long-term follow-up is required for any urinary or bowel dysfunction.
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1. Introduction
Sacrococcygeal teratoma is the most common congenital neoplasm. The word “ter-
atoma” is derived from the Greek word “teratos” meaning monster. The first reported 
case was described on a cuneiform tablet dated approximately 2000 BC. Advances 
in antenatal imaging have let to prenatal detection of most SCTs and may avoid early 
mortality. Delayed presentation and presence of malignant elements continue to be 
poor prognostic factors, while surgical goal remains complete resection.
2. Background
Although rare, SCT is the most common tumor of the fetus and the newborn, 
with a reported prevalence of 0.25–0.28:10,000 live births. With more advance-
ments in US (ultrasonography), more SCT are diagnosed prenatally.
2.1 Etiology
SCT arises from pluripotent cells of Hense’s node that is present/located anterior 
to coccyx, a remnant of the primitive streak in the coccygeal region. The primitive 
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streak is a longitudinal ridge of ectodermal cells at the caudal end of the bilaminar 
embryonic disc. It consists of totipotent cells, which are able to transform into any 
type of cells. This structure determines the future craniocaudally axis of the embryo 
and demarcates the embryo into left and right halves. If totipotent cells of the 
primitive streak remain after the fourth week, these cells give rise to a SCT [1].
SCT is a relatively uncommon tumor affecting neonates, infants and children.
SCT represents a group of benign and malignant tumors deriving from the 
primordial germ cells. Pediatric germ cell tumors (GCTs) are neoplasms derived from 
primordial germ cells and may occur both inside the gonads and extragonadal organs. 
The five main histologic categories of GCTs are: dysgerminomas (in the ovary), 
seminomas (in the testes), teratomas, choriocarcinomas and endodermal sinus tumor 
(ESTS) or Yolk sac tumor. The most common site of extragonadal GCTs in the pediat-
ric population is the sacrococcygeal region and the most common type are teratomas.
The sacrococcygeal region is the most frequent location for teratomas, but 
teratomas may occur in almost any organ, tending to develop more commonly in 
midline or paraxial location and can be observed from the brain (cephalad) to the 
coccyx (caudal). Less common sites are the mediastinum, testes, ovary, retroperito-
neum, head [2, 3].
Females are affected more frequently with a female to male ratio of almost 
4:1.78. SCT are either mature, immature or malignant, composed of embryonic 
elements. A mature SCT is a benign tumor containing only mature components, 
while immature SCT contains immature tissues. SCT that contains malignant ele-
ments are considered to be malignant tumors. Mature and immature teratomas are 
considered as benign tumors and may undergo malignant transformation. At birth, 
the great majority of SCTs are benign. They can manifest malignant transformation 
with advanced age.
They appear as cystic tumors or solid. The cystic may be filled with serous fluid, 
mucoid or sebaceous material, or even cerebrospinal fluid. Virtually any tissue 
can be present in a SCT. Neuroglial tissue, skin, respiratory and enteric epithelium 
cartilage, smooth muscle and striated muscle fibers are the most common elements 
found. Also bone, pancreatic tissue, choroid plexus and adrenal tissues are less 
commonly identified.
2.2 Classification
Size of a SCT (average 8 cm diameter, range 1–30 cm) does not predict its 
biological behavior. Altman et al. defined the size of SCT as follows:
Small: as 2–5 cm diameter
Moderate: 5–10 cm
Large: >10 cm.
Antenatal diagnosis is important to avoid complications during delivery. Fetal 
US and MRI are the mainstay of antenatal diagnosis of SCT. MRI is more accurate 
in describing the intrapelvic and abdominal extent of the tumor and provides more 
information on compression of adjacent organs. Prenatal assessment of the fetus 
is critical for counseling the parents and planning surgical options. Because of 
acoustic shadowing by the fetal pelvic bones, US cannot always define the extent of 
SCT. Fetal MRI has been successfully performed to evaluate anatomy, content and 
extent of the tumor, but just a few small cases series have been published yet.
SCT arise from the base of the coccyx and may continuously grow in the poste-
rior direction forming an external protrusion, or in the anterior direction, dissect-
ing and distorting surrounding structures such as the rectum, vagina and bladder, 
but without invading them. Based on this morphologic characteristic, Altman et al. 
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have been defined The American Academy of Pediatrics Surgical Section (APPSS) 
classification [3–5]:
Type I: predominantly external with minimal presacral component—45.8%
Type II: present externally, but with significant intrapelvic extension—34%
Type III: apparent externally but predominantly a pelvic mass extending into the 
abdomen—8.6%
Type IV: presacral mass with no external presentation—9.6%.
2.3 Histology
SCT are graded histologically as follows:
Grade 0—tumor contains only mature tissue
Grade 1—tumor contains rare foci of immature tissues
Grade 2—tumor contains moderate quantities of immature tissues
Grade 3—tumor contains large quantities of immature tissue with or without 
malignant yolk sac elements.
3. Diagnosis
3.1 Intrauterine diagnosis
The majority of SCT present between the 22nd and the 34th week of gestation. 
The diagnosis of SCT on routine US is associated with a greater than expected inci-
dence of prenatal and perinatal complications. Close antenatal follow up is needed 
to optimize patient counselling and treatment in the presence of a completely solid 
tumor and the onset of polyhydramnios. A poor outcome is usually correlated with 
placentomegaly, cardiomegaly or non-immune hydrops fetalis.
3.2 Associated anomalies
Associated congenital malformations are observed in 12–15% of cases and 
occur more frequently with presacral tumors. The incidence of various congenital 
malformations associated with SCT ranges from 5 to 26%. Of these, anorectal and 
genital malformations are most commonly. A growing SCT during the first weeks of 
embryonic life will encroach between the layers of the cloacal membrane and pre-
vent descent and fusion of the urorectal septum to the cloacal membrane, resulting 
in a high anorectal malformation with a rectourethral or rectovestibular fistula. The 
presence of SCT in the same period of time (47th weeks), when cloaca is subdivided 
by the urorectal septum to form the anorectal canal and the primitive urogenital 
sinus, could prevent fusion of the genital folds, resulting in a bifid scrotum or 
hypospadias. The most commonly observed anorectal defects are: imperforate anus, 
anorectal stenosis and common vertebral anomalies are: sacral hemivertebrae, 
absence of the sacrum and coccyx [6].
Other associated anomalies include spinal dysraphism, sacral agenesis, disloca-
tion of the hips and meningocele. Rarely, gastrointestinal or cardiac defects are 
associated with SCT.
Currarino triad represents association of anorectal malformation, sacral dyspla-
sia and presacral mass. Delay in diagnosis of the presacral lesion is common because 
a rectal examination may not be possible in many cases with anorectal stenosis. 
Presenting symptoms in some of these unusual cases include perirectal abscess or 
fistula in ano (Figure 1).
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3.3 Clinical presentation
Most external tumors are asymptomatic, with the exception of the presence of a 
visible exophytic large mass at the sacral region with occasional surface ulceration 
and hemorrhage and with anus displaced anteriorly (Figure 2). Sometimes, rupture 
of the tumor may occur as a result of a difficult delivery. Pelvic tumors or tumors 
that extend into the abdominal cavity may present with compression of the rectum 
or recto-sigmoid and urinary tract obstruction (constipation, frequent stools, 
obstruction of the bladder neck).
3.4 Diagnostic tools
Except for clinical examination, there are a variety of radiographic studies that 
can help. Plain X-Ray may show the presence of calcification within the tumor and 
anterior displacement of the rectum by the tumor. The sacrum may appear abnor-
mal (such as hemivertebrae, agenesis).
Computer tomography (CT) or MRI of the pelvis with intravenous contrast 
material may reveal urinary tract displacement or obstruction and outlines the 
extent of the tumor more accurately. MRI is also a useful diagnosis of spinal cord 
extension of tumor (Figure 3).
A chest X-Ray or CT thoracic scan is obtaining to rule out the presence of 
pulmonary metastases.
Malignant SCT may have elevated tumor markers. The most commonly pro-
duced tumor marker is AFP (alpha-fetoprotein) because yolk sac components are 
the most common malignant elements. Other malignant elements may produce beta 
HCG (human chorionic gonadotropin). Serum AFP and beta HCG should be evalu-
ated at the initial diagnostic work-up and assessed to monitor tumor relapse during 
the follow up period. The use of AFP as a tumor marker is well established and 
persistent, elevated level may indicate a residual tumor, recurrence or malignant 
degeneration. Because AFP is produced by fetal liver and fetal gastrointestinal tract, 
Figure 1. 
Currarino triad in a female patient with SCT—MRI. Red arrow points the SCT. The girl presented with 
imperforate anus, recto-vestibular fistula and SCT was misdiagnosed until MRI.
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its level is normally elevated in the first 8 months of life and after that age it rapidly 
falls to normal adult level (10 ng/ml). The mean time required for AFP to normalize 
after SCT resection is about 9 months [7, 8].
The differential diagnosis of SCT include rectal duplication, meningocele, 
lipoma, chordoma, epidermoid cyst, neuroblastoma.
Figure 2. 
SCT type II in a newborn girl. Large mass visible in sacral region, with displacement of anal orifice.
Figure 3. 
Type II SCT with intrapelvic component—MRI.
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4. Management
4.1 Prenatal management
Fetal MRI is a powerful addition to the prenatal evaluation of fetuses with 
SCT. Due to the fact that, in most cases, neonatal surgery is required soon after 
cesarean section, the anatomic details of tumor extent and involvement of adjacent 
structures may affect the surgical approach. Patients with significant intrapelvic 
extension of the tumor may need a combined abdominoperineal approach to 
control the blood supply and achieve complete resection. All these may contribute 
to avoid resection-related complications during surgery [9] (Figure 4).
Monitoring for fetal distress during pregnancy is very important. Some large 
tumors have a very high blood flow that causes a shift in blood flow away, producing 
fetal hydrops. Other possible complications are bleeding inside the tumor, polyhy-
dramnios and preterm labor. A rare condition is called “mirror syndrome” where 
the mother mirrors the baby’s sickness, leading to fluid retention, preeclampsia, 
high blood pressure, heart failure [10, 11].
4.2 Surgical management
Most fetal teratomas could be managed by planned delivery and postnatal 
surgery. The earlier the diagnosis and surgical intervention, the better the progno-
sis. A complete surgical excision of the tumor including coccygectomy is necessary, 
in order to avoid recurrence. A long term observation and follow-up is required for 
any urinary or bowel dysfunction.
Mature teratomas should not recur, if complete surgical excision and coccy-
gectomy were achieved properly. Recurrence is reported in literature, as 2–35%, in 
patients with immature teratomas operated after the age of 5 months and is related 
to tumor spillage or incomplete excision.
At the time of birth, most lesions are benign and surgical resection can be 
accomplished with relatively low morbidity and mortality. The incidence of 
Figure 4. 
Antenatal diagnosis of SCT using MRI and measurements.
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malignancy in SCT is increasing with age. Failure to remove the coccyx results in 
30–40% recurrence rate, with a higher probability of malignancy. Alpha fetoprotein 
may be used to detect early occurrence of malignancy.
Management of SCT depends on fetal lung maturation and presence of placental 
enlargement and/or fetal hydrops. When maturity of fetal lung without placental 
enlargement and/or hydrops fetalis, planned cesarean section is indicated. Some 
authors recommend preventive early delivery by cesarean section when the tumor 
exceeds the diameter of 5 cm, to avoid complications such as rupture and hemor-
rhage. The primary treatment of SCT is early surgical resection with complete exci-
sion of the coccyx. Early surgical intervention is associated with better prognosis. 
The surgical approach depends on the degree of pelvic extension. Posterior sacral 
approach is recommended in type I and II, and combined abdominal and posterior 
sacral approaches in type III and IV. The technique of wide resection of benign 
lesions with coccygectomy is helpful in preventing recurrence and has changed 
little over the last four decades.
The goals of surgical resection of an SCT are:
• Complete resection of the tumor
• Removal of the coccyx
• Reconstruction of the pelvic floor and ano-rectal sphincter
• Acceptable cosmetic appearance
After inserting a urinary catheter, the patient is placed in the prone jack-knife 
position. A V-shaped incision is made at the superior margin of the tumor. It is 
important to identify the course of the anus by placing a tube in the anal canal. 
After raising skin flaps, the muscles are dissected from the tumor which must be 
resected with the coccyx, after ligation of its main blood supply, which are middle 
sacral artery or branches from the hypogastric arteries [4, 7, 12].
Figure 5. 
Large SCT in a newborn—preoperative. SCT represents more than 50% of birthweight, with visible  
ulceration of the skin.
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The multiorgan involvement makes the anesthetic management challenging. 
Prematurity and hypothermia are risk factors for coagulopathy and can lead to fatal 
consequences. Management of intraoperative bleeding and early extubation are 
good outcome predictors [5, 13, 14] (Figure 5).
Patients with malignant SCT are managed after surgery with irradiation if 
residual disease is present, and chemotherapy. Most tumors have a plane of dis-
section and can be removed easily. It is safer and recommended to catheterize the 
bladder to keep it away from the tumor and place a large rubber catheter in rectum 
for identification. Levator ani muscles are often stretched over tumor and should 
be reconstructed after tumor is excised. Drainage is necessary as there is a large raw 
area and collections should be avoided (Figure 6).
Preservation of the autonomous nerve supply to the bladder and rectum may be 
difficult. Therefore, postoperative complications (31%) that may be expected are 
bladder dysfunction, incontinence for feces and dysesthesia. The main postopera-
tive early complication is wound infection because of the proximity to the anus and 
the skin flaps that may be needed.
5. Conclusions
SCT is a common neonatal neoplasm. Antenatal diagnosis is essential, for 
avoiding complications and high morbidity, mortality. Delivery in a tertiary center 
by cesarean section, when needed, should be emphasized. Early diagnosis and 
complete resection of the tumor with removal of the coccyx is associated with good 
prognosis.
Figure 6. 
Same newborn—postoperative view, after removal of SCT.
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